---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-21-067652"
form_type: "8-K"
ticker: "ADTX"
cik: "0001726711"
company_name: "Aditxt, Inc."
filed_at: "2021-12-28T23:59:59+00:00"
generated_at: "2026-06-27T22:10:03.072470+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Aditxt to acquire AiPharma in all-stock deal valued at ~44.7M shares plus $500K cash

## Summary
- Initial closing by Jan 31, 2022 for 9.5% of AiPharma: 4.8M shares + $250K cash.
- Secondary closing for remaining 90.5% subject to shareholder and Nasdaq approval: 39.9M shares + $250K cash.
- AiPharma holds exclusive rights to Avigan (favipiravir) for COVID-19; Phase 3 trial missed primary endpoint.
- Two board members, Lauren Chung and Laura Anthony, resigned effective Dec 31, 2021; no disagreement cited.
- AiPharma has strategic alliance with Appili Therapeutics (TSX:APLI) and plans new global clinical trial for Avigan.

## SEC filing metadata
- accession: 0001213900-21-067652
- form_type: 8-K
- ticker: ADTX
- cik: 0001726711
- company_name: Aditxt, Inc.
- filed_at: 2021-12-28T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1726711/000121390021067652/0001213900-21-067652-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1726711/000121390021067652/ea153046-8k425_aditxtinc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-21-067652
- JSON: https://secwatch.observer/filing/0001213900-21-067652.json
- Plain text: https://secwatch.observer/filing/0001213900-21-067652.txt

## Key facts
- Executive change
  Laura Anthony resigned as Director at Aditxt, Inc..
  - Action: resigned
  - Role: Director
  source text: On December 26, 2021, Laura Anthony notified the Company that effective December 31, 2021, she is resigning from the Company’s Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1726711/000121390021067652/0001213900-21-067652-index.htm
- Executive change
  Lauren Chung resigned as Director at Aditxt, Inc..
  - Action: resigned
  - Role: Director
  source text: On December 24, 2021, Lauren Chung notified the Company that effective December 31, 2021, she is resigning from the Company’s Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1726711/000121390021067652/0001213900-21-067652-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.